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Pax6 is a developmental control gene with an essential role in development of the eye, brain and pancreas. Pax6, as many other developmental
regulators, depends on a substantial number of cis-regulatory elements in addition to its promoters for correct spatiotemporal and quantitative
expression. Here we report on our analysis of a set of mice transgenic for a modified yeast artificial chromosome carrying the human PAX6 locus.
In this 420 kb YAC a tauGFP-IRES-Neomycin reporter cassette has been inserted into the PAX6 translational start site in exon 4. The YAC has
been further engineered to insert LoxP sites flanking a 35 kb long, distant downstream regulatory region (DRR) containing previously described
DNaseI hypersensitive sites, to allow direct comparison between the presence or absence of this region in the same genomic context. Five
independent transgenic lines were obtained that vary in the extent of downstream PAX6 locus that has integrated. Analysis of transgenic embryos
carrying full-length and truncated versions of the YAC indicates the location and putative function of several novel tissue-specific enhancers.
Absence of these distal regulatory elements abolishes expression in specific tissues despite the presence of more proximal enhancers with
overlapping specificity, strongly suggesting interaction between these control elements. Using plasmid-based reporter transgenic analysis we
provide detailed characterization of one of these enhancers in isolation. Furthermore, we show that overexpression of a short PAX6 isoform
derived from an internal promoter in a multicopy YAC transgenic line results in a microphthalmia phenotype. Finally, direct comparison of a
single-copy line with the floxed DRR before and after Cre-mediated deletion demonstrates unequivocally the essential role of these long-range
control elements for PAX6 expression.
© 2006 Elsevier Inc. All rights reserved.Keywords: Pax6 gene regulation; Long-range enhancer; Transgenic mouse; Yeast artificial chromosome; Green fluorescent protein; Eye development; Paired-less
isoform; MicrophthalamiaIntroduction
Gene regulation at the level of transcription requires the
presence of a promoter, sometimes in conjunction with
additional cis-regulatory elements such as enhancers and
repressors. Developmental control genes form a particular
class of genes with respect to their transcriptional regulation, as
they often display highly complex spatiotemporal as well as
quantitative expression patterns. Their expression needs to be
induced or switched off at the right time and place in the
embryo. Errors in the site, timing or levels of expression often⁎ Corresponding author. Fax: +44 131 467 8456.
E-mail address: dirkjan@hgu.mrc.ac.uk (D.A. Kleinjan).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.08.060lead to developmental malformations. To achieve such tightly
controlled expression profiles many developmental control
genes require the coordinated actions of a large number of cis-
regulatory elements. These control elements can be spaced over
large distances both upstream and downstream of the gene, and
can even be located beyond or within introns of adjacent genes.
Thus developmental regulators often reside in complex
regulatory genomic landscapes (Kleinjan and van Heyningen,
2005). To achieve a better understanding of the genetic
networks that govern the development and maintenance of
our organ systems it is necessary to elucidate the molecular
mechanisms controlling their transcription. As the cis-regula-
tory elements of developmental control genes form the hard-
wiring of such networks in the genome (Davidson, 2001), their
identification and characterization are an essential first step in
564 D.A. Kleinjan et al. / Developmental Biology 299 (2006) 563–581this process. Pax6 is such a developmental regulator with many
different functions during the development and maintenance of
the eye, pancreas and central nervous system (Simpson and
Price, 2002; Ashery-Padan and Gruss, 2001; Callaerts et al.,
1997). A full characterization of the cis-regulatory elements
required for Pax6 transcription in different tissues will not only
be essential for studying the molecular mechanisms controlling
its expression, but also greatly enhance the identification of the
trans-acting factors binding to these elements, leading ulti-
mately to a better definition of the regulatory networks that
specify eye, brain and pancreas development.
Pax6 is a transcription factor with two DNA-binding
domains. The paired domain located at the N-terminus is
separated by a glycine-rich linker sequence from the second
DNA-binding domain, the homeobox, followed by a proline–
serine–threonine-rich transactivation domain at the C-terminus.
It is highly conserved in very diverse range of species. In
mammals, it is expressed in a complex spatiotemporal pattern
during development of the retina, lens and cornea, in regions of
the forebrain, hindbrain, cerebellum and spinal cord, the
olfactory system and in pancreatic islet cells (Walther and
Gruss, 1991; Stoykova and Gruss, 1994; Grindley et al., 1997;
Quinn et al., 1996; St. Onge et al., 1997; Warren and Price,
1997; Dohrmann et al., 2000).
The importance not only of the correct spatiotemporal
pattern, but also of the right level of expression is shown by the
fact that haploinsufficiency for Pax6 function (Pax6+/−) in the
mouse results in the Smalleye (Sey) phenotype. Homozygotes
(Pax6−/−) die perinatally with no eyes, no nasal structures and
multiple severe brain abnormalities (Hogan et al., 1986; Hill et
al., 1991; Stoykova et al., 1996; Caric et al., 1997; Warren and
Price, 1997; St Onge et al., 1997; Mastick et al., 1997; Warren et
al., 1999; Engelkamp et al., 1999; Pratt et al., 2000; Estivill-
Torrus et al., 2001; Haubst et al., 2004). In humans, PAX6
haploinsufficiency is the cause of the congenital eye malfor-
mation aniridia (Ton et al., 1991; Jordan et al., 1992; Glaser et
al., 1992), and has more recently also been shown to cause brain
defects (Sisodiya et al., 2001). Conversely, it was shown that
overexpression of Pax6 in mice also leads to severe eye
abnormalities (Schedl et al., 1996). In Drosophila, misexpres-
sion of the eyeless gene in imaginal disc primordia can lead to
the formation of ectopic eyes (Halder et al., 1995). In the brain a
Pax6 gradient across the developing neocortex of mice is
thought to be important for correct specification of its major
areas (Bishop et al., 2000; Muzio et al., 2002). These findings
imply that Pax6 expression requires tight regulation and that
different levels need to be maintained in different regions of the
embryo.
Transcriptional control of Pax6 expression has been the
subject of a number of studies (Plaza et al., 1995a,b; Williams et
al., 1998; Kammandel et al., 1999; Xu et al., 1999; Kleinjan et
al., 2001, 2004; Griffin et al., 2002; Kim and Lauderdale, 2006),
resulting in the identification of several cis-regulatory elements
through reporter assays in transgenic mice. While some of the
cis-elements are found upstream and within introns of the gene,
the presence of more, distant control elements downstream of
the gene was brought to light through the analysis of humananiridia patients (Fantes et al., 1995a,b; Kleinjan et al., 2001).
Whereas aniridia is generally caused by mutations or deletions
that inactivate the protein product, a subset of aniridia patients
was shown to have two intact copies of the PAX6 transcription
unit. Instead some of these patients were found to carry
chromosomal rearrangements with breakpoints in the 11p13
region downstream of PAX6 (Fantes et al., 1995b; Lauderdale et
al., 2000; Crolla and van Heyningen, 2002), suggesting that the
PAX6 promoters were separated from essential regulatory
elements in the rearranged chromosomes. This view was
reinforced by the analysis of human/mouse somatic cell hybrids
with normal and rearranged patient chromosomes showing that
expression from the rearranged chromosome was abolished
(Lauderdale et al., 2000). The most distant patient breakpoint,
SIMO, was located at 124 kb downstream from the PAX6
polyadenylation site. Analysis of the region beyond this
breakpoint using YAC transgenic mice, DNaseI hypersensitiv-
ity mapping and reporter transgenic assays revealed the
presence of several putative cis-regulatory elements, including
ones driving expression in lens and retina (Kleinjan et al.,
2001). These elements reside within introns of the adjacent,
ubiquitously expressed ELP4 gene, but are nevertheless thought
to be PAX6-specific long-range control elements (Kleinjan et
al., 2002). Collectively these elements were termed the
downstream regulatory region (DRR). Since then the availabil-
ity of genomic sequence from a diverse range of species,
enabling interspecies sequence comparisons, has demonstrated
the presence of an unusually large number of evolutionarily
conserved regions (ECRs) around the PAX6 gene. As ECRs are
generally reliable indicators of the presence of cis-regulatory
sequences, the presence of many more, as yet uncharacterized
transcriptional control elements can be inferred.
One notable observation from the transgenic reporter studies
described thus far is that several cis-elements drive expression
with overlapping tissue specificity, suggesting that they may act
via cooperative interactions in the endogenous locus. Such
cooperative interactions are not taken into account in studies
with plasmid-based reporter transgenics, which are also
frequently hampered by position effects due to site of
integration of the reporter cassette.
To study the long-range control of PAX6 expression, in
particular the role of the DRR, we have generated transgenic
reporter mice carrying one of two newly modified yeast artificial
chromosomes (YAC) that report on the level of gene activation
by production of GFP. Analysis of the pattern of GFP expression
in a full-length single-copy line allowed us to demonstrate
functional conservation between the human and mouse
regulatory potential encoded in the full-length locus (Tyas et
al., 2006). Here we describe the detailed analysis of six
transgenic lines that vary in the extent of downstream PAX6
sequence that has integrated. Analysis of full-length and
truncated YAC transgenes reveals the location and putative
function of several novel tissue-specific enhancers. It also
demonstrates that the absence of specific distal enhancers
prevents expression of the reporter despite the presence of more
proximal enhancers capable of driving expression in the same
tissue. Complementary plasmid-based reporter transgenic
565D.A. Kleinjan et al. / Developmental Biology 299 (2006) 563–581analysis was used in some instances for detailed characterization
of novel putative enhancers revealed by the YAC experiment.
Comparative analysis, before and after Cre-mediated deletion,
between a single-copy line carrying the YAC in which the DRR
was flanked with LoxP sites, unequivocally demonstrates the
essential role of these long-range control elements for PAX6
expression in some but not all tissues.Materials and methods
Generation of the YAC transgenic reporter mice
The construction of YAC Y1123 has been described (Tyas et al., 2006). In
short, a tau-GFP reporter followed by an IRES-neomycin resistance cassette was
inserted in frame into the translation start site in exon 4 of the PAX6 gene in a
yeast targeting vector. This construct was recombined into YACY593 (Schedl et
al., 1996) using URA3 as selectable marker, and the wildtype exon4, plasmid
backbone and URA3 gene subsequently removed by counter selection in 5′
FOA to generate Y1123. A first loxP site was inserted into this YAC by
homologous recombination of a LoxP-URA3-LoxP cassette at a position 140 kb
downstream from the P1 promoter. The URA3 gene was removed by transient
expression of Cre enzyme under control of the yeast GAL10 promoter. Finally a
second LoxP site as well as a FRT site were inserted at a position 175 kb
downstream from the P1 promoter using a targeting construct containing URA3,
which was subsequently removed by 5′FOA counterselection. The resulting
YAC was named Y374.
DNA was prepared for microinjection as described (Tyas et al., 2006), and
microinjected into pronuclei from oocytes of F1 mice from a (C57/Bl6×CBA)
cross. Injected oocytes were replaced in pseudopregnant CD1 fosters (Hogan et
al., 1994). Transgenic animals were identified by earclip analysis. All
subsequent crosses were onto a CD1 background. Autoregulation effects were
assessed by crossing transgenic line RBZ-146 with CD1 Pax6SeyEd/+ mice, and
by further crossing of a RBZ-146 transgenic heterozygous Pax6SeyEd/+ male
with a Pax6SeyEd/+ female.
YAC transgenic lines were identified by PCR on DNA isolated from earclips
according to standard procedures. Primers used to assay for the presence of the
human PAX6 locus in the transgenic lines are
Pr025: 5′-CAAACAGGTTTAAAGACATTG-3′
Pr026: 5′-ACAGAGGTGCTTGTACAGAGT-3′
Primers used to detect the presence of the YAC arms:
YR1: 5′-ATATAGGCGCCAGCAACCGCACCTGTGGCG-3′
YR2: 5′-GTAATCTTGAGATCGGGCGTTCGA-3′
YL1: 5′-CACCCGTTCTCGGAGCACTGTCCGACCGC-3′
YL2: 5′-CCTTAAACCAACTTGGCTACCGAGA-3′
Primers used to determine the extent of the human PAX6 locus integrated in
the various transgenic lines:
Pr028: 5′-CACTGTGCTTTTAAAAAGATAC-3′
Pr057: 5′-CCCATGGGCTACCTGTGC-3′
Pr126: 5′-TTACAATCTCCAGAGGTGGCA-3′
Pr127: 5′-TGTACTTAAACAGTGCTGGCA-3′
Pr128: 5′-ATGCCTCCATATCAACCTAGA-3′
Pr260: 5′-ACAGGGACACAACACTTCGCA-3′
Pr150: 5′-CCTATTCTTAAAATGTTTCTCTGT-3′
Pr151: 5′-AAGATCAGGCAGTAGGTAGGA-3′
Pr154: 5′-ATTTTGGTTCACAACGCCTTGCCT-3′
Pr155: 5′-GGCTTTCTATTTCTGGCTCTGCTG-3′
Pr267: 5′-CTGCGACAAGTTGGATGTGGT-3′
Pr268: 5′-ACTGGTGTATCTCTGATGGCT-3′
Pr363: 5′-TCACATACTTCCCTTTGCAAACCT-3′
Pr374: 5′-AGGACATAGCAGAGCTTTTGTGGA-3′Pr375: 5′-AGGTGTTTAACATCCATTGGGAGA-3′
Pr399: 5′-TCTAGCACTATGCATCTTTAGGT-3′
Pr400: 5′-TATGAGCACGGAGTCTAATTAGG-3′
Theywere used in the following combinations as shown in Fig. 1: Primer set I,
YR1 andYR2; set II, Pr267 and Pr268; set III, Pr025 and Pr026; set IV, Pr 374 and
Pr375; set V, Pr028 and Pr057; set VI, Pr399 and Pr400; set VII, Pr128 and Pr260;
set VIII, Pr150 and Pr151; set IX, Pr154 and Pr155 and set X, YL1 and YL2.
For FISH analysis, spleens were dissected from transgenic mice, washed in
PBS, punctured repeatedly with a sterile needle and splenocytes flushed out by
forcing through 2 ml of RPMI. Lipopolysaccharide (LPS) was added and the
culture incubated for 46 h. FISH was performed as described (Fantes et al.,
1995a). Probes used were human cosmids cP60, located upstream from PAX6,
cFAT5 (EMBL accession number Z95332) containing PAX6 and cosmids
cC1170 (Z83306) and c11M20 (Z83308) located downstream from PAX6.
To study the expression patterns generated by the YAC transgenic mice
embryos were dissected from pregnant females at E9.5, E10.5 and E17.5, taking
the morning of the appearance of a vaginal plug as E0.5. Embryos were washed
in PBS and examined and photographed immediately after dissection on a Leica
MZ FLIII Microscope fitted with a Hamamatsu Orca-ER digital camera. For the
E17.5 eye sections the eyes were removed from the embryo, washed in PBS and
fixed overnight in 4% paraformaldehyde. Next morning the eyes were washed in
PBS, and processed for sectioning on the cryostat. Sections were cut at 20 μ and
counterstained with DAPI.
Production and analysis of RB-Z reporter transgenic mice
The RB-Z reporter construct was made as follows: A 1.8-kb fragment was
PCR amplified from cosmid c9A13 (EMBL accession number Z86001) using a
high fidelity Pfu polymerase mix with PCR primers containing XhoI restriction
sites. This fragment was subcloned into the SalI site of the p610+ reporter
construct containing a Hsp68 minimal promoter-LacZ cassette as described for
other PAX6 enhancers (Kleinjan et al., 2001). The microinjection fragment was
isolated following digestion with NotI and Asp718I, and microinjected
according to standard procedures. Transgenic mice and embryos were
identified by PCR using LacZ-specific primers. Embryos were collected at
the appropriate stages, washed in PBS and fixed for 1 h in a solution of 1%
formaldehyde; 0.2% glutaraldehyde; 2 mM MgCl2; 5 mM EGTA and 0.02%
NP-40 in PBS. After fixation the embryos were washed in PBS containing
0.02% NP-40, before being stained for several hours at 37°C in the dark in a
solution containing 5 mM K3Fe(CN)6; 5 mM K4Fe(CN)6.3H2O; 2 mM MgCl2;
0.01% sodium deoxycholate; 0.02% NP-40 and 0.1% 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-gal). Embryos were photographed on a
Leica MZ FLIII Microscope fitted with a Hamamatsu Orca-ER digital camera
with a CRI micro-color filter.
RNA extraction and RT-PCR
RNAwas isolated from dissected heads of E10.5 transgenic mouse embryos
as well as non-transgenic littermates using TRI reagent (Sigma). The PAX6-
expressing cell line CD5a was used as a control template for the human PAX6
locus. RT-PCR (33 cycles) was performed using AMV reverse transcriptase and
random hexamers for first strand synthesis (Roche). Specific PCR primers used
were:
Pr3F1675: 5′-GAGAGTGGACAGACATCCG-3′ (human exon 3 forward
primer);
Pr αF: 5′-TCCTGGCGTCAATTTATCAGT-3′ (human exon α forward
primer);
Pr050: 5′-TAGATCTATTTTGGCTGCTAGTC-3′ (reverse primer in exon 9);
The ubiquitously expressed ELP4/Elp4 gene (Kleinjan et al., 2002) was used
as control for the RNA isolation and reverse transcriptase reaction. Primers used
were:
Pr087: 5′-GCGACCGTCGGTGCGGAATGG-3′;
Pr088: 5′-AGAACATAGAGGAACTTGGTAAG-3′
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Generation of PAX6 reporter YACs and characterization of
transgenic lines
The two modified YACs used in this study are based on YAC
Y593, which contains 420 kb of the human PAX6 coding
sequence and flanking regions, extending beyond its putative
regulatory elements. YAC593 has been shown to rescue the
heterozygous eye phenotype and homozygous lethality of the
mouse smalleye (Pax6sey/sey) phenotype, whereas a shorter
YAC (Y589) containing 110 kb less flanking sequence did not
(Fig. 1A) (Schedl et al., 1996; Kleinjan et al., 2001). From these
results it was assumed that YAC593 contains all necessary cis-
regulatory elements required for PAX6 expression. We have
modified the YAC by introducing a tau-GFP and neomycin
resistance cassette at the translational start site in exon 4, so that
expression of the reporter cassette would be controlled by the
PAX6 regulatory elements and would prevent the production of
PAX6 protein from the YAC. This YAC was called Y1123 (Fig.
1B) (Tyas et al., 2006). The YAC has been further engineered to
insert LoxP sites around the 35 kb long, distant downstream
regulatory region (DRR) containing previously described DHS
sites, to allow direct comparison between the presence or
absence of this region in the same genomic location. Thus, a
LoxP site was inserted at a position 145 kb downstream from
the P1 promoter, about 3 kb upstream from the SIMO
breakpoint. A second LoxP site, as well as an FRT site, was
inserted 175 kb downstream from the P1 promoter, beyond the
most distal DHS site mapped in Kleinjan et al., 2001. This YAC
was called Y374 (Fig. 1B). Both YACs were used to generate
transgenic mice. Five independent transgenic lines (two with
Y1123: DTy22 and DTy54, and three with Y374: Y001, Y028
and Y223) were selected for further study.
We first determined how much of the YAC had integrated in
the transgenic lines, their copy number and whether the
transgenes were intact or fragmented. PCR and Southern
blotting with human-specific probes and primers was used to
determine the extent of the YAC integrated in the mouse
genome (Fig. 1C). Metaphase and interphase FISH on spleen
cells from adult transgenic mice with cosmid probes derived
from the human PAX6 locus was used to determine the copy
number, whether the integrated YAC DNA was intact or
fragmented across the genome, and to confirm the extent ofFig. 1. (A) Physical map of the human PAX6 locus. The relatively compact PAX6 tran
downstream from PAX6 and transcribed in opposite direction is the ubiquitously exp
exons. Red circles indicate the positions of some significant enhancers. The positio
indicated (Fantes et al., 1995a,b). Black horizontal arrows indicate known PAX6 pro
sites (HS) that mark a region termed the PAX6 downstream regulatory region (DRR).
is indicated below the physical map. Y593 extends 200 kb downstream from the fina
small eye phenotypes (Schedl et al., 1996), while Y589 extending 125 kb downstream
tGFP-IRES-Neomycin-polyA-C2MAZ cassette (Tyas et al., 2006) in frame into the P
to insert a LoxP site in a position just upstream from the SIMO patient breakpoint and
to generate a YAC, Y374, with a LoxP flanked region of 35 kb that includes the DRR
of integration of the YACs in independent transgenic lines are indicated by roman nu
sets indicated in panel B. All lines were positive for primer sets in the upstream and i
here, but differed in the extent of downstream region that had integrated. M, marker;
line Y374/223; 6, non-transgenic mouse; 7, line DTy22; 8, line DTy54; 9, line PAXYAC DNA present. The positions of the cosmids used as probes
(cP60, cFAT5, cC1170 and c11M20) are indicated in Fig. 2A.
The FISH results show that four lines, DTy22, DTy54, Y001
and Y028 are single copy. The fifth line, Y223, appears to have
six copies of the YAC, arranged in a head to head and tail to tail
sequence, based on analysis of several interphase nuclei (Fig.
2C). PCR analysis and FISH data with probes P60 and FAT5
indicate that all five lines contain the full extent of upstream
sequence, including the left YAC arm. However, analysis of the
region downstream from PAX6 indicates that only DTy54 and
Y223 contain the full extent of the YAC, while DTy22, Y001
and Y028 are all truncated. The extent of DNA contained in
these lines varies and is shown in Fig. 2D. Y001 lacks only a
small region of between 10 and 20 kb from the very end of the
YAC. DTy22 truncates between 50 and 75 kb downstream from
the PAX6 P1 promoter, just before the E100 (previously called
C1170/Box123) enhancer (Griffin et al., 2002). Y028 carries the
shortest transgenic insertion, truncating between ELP4 exon 10
and a highly conserved sequence termed E60+ (Kleinjan et al.,
in preparation), thus containing the complete PAX6 coding
region, but excluding nearly the entire downstream region.
Analysis of GFP reporter expression in the YAC transgenic
lines
We next examined the expression patterns of the GFP
reporter in transgenic embryos collected at E9.5, E10.5, and
E17.5. Expression of τGFP in the full-length transgenic lines
Y223 and DTy54 was identical to the known Pax6 expression
pattern at all ages examined, with minor exceptions as described
below. The expression patterns obtained from line Y223,
carrying YAC374, and DTy54, carrying YAC1123, were
identical at all stages, indicating that the insertion of the LoxP
sites into YAC374 does not affect expression of the reporter
cassette. The signal in Y223 embryos was generally stronger, in
line with the higher copy number in this transgenic line. Thus, in
both Y223 and DTy54 τGFP expression was observed in all
tissues of the eye, including retina, lens and surface ectoderm,
and in forebrain, hindbrain, spinal cord and olfactory system in
a pattern mirroring endogenous Pax6 expression at E9.5, E10.5
and E17.5. Specifically, at E9.5 expression of the reporter was
seen in telencephalon, prosomeres 1, 2 and 3 of the
diencephalon, rhombomeres 2 to 8 of the hindbrain and
caudally along the spinal cord. In the developing eye expressionscription unit occupies a 25-kb fragment on human chromosome 11p13. Located
ressed ELP4 gene. Blue rectangles indicate PAX6 exons, open rectangles ELP4
ns of the breakpoints in some aniridia patients with a PAX6 position effect are
moters. Red vertical arrows show the position of a set of DNaseI hypersensitive
The extent of the locus contained in the 420 kb YAC Y593 and the 310 kb Y589
l PAX6 exon and has been shown to rescue both heterozygous and homozygous
does not (Kleinjan et al., 2001). (B) Y593 has been modified by insertion of a
AX6 ATG startcodon to generate YAC Y1123. Y1123 has been further modified
a second LoxP site as well as an FRT site downstream from the furthest HS site,
. The positions of human-specific PCR primer sets used to characterize the extent
merals below Y374. (C) Gel photos of PCR fragments obtained with the primer
ntronic region of the PAX6 locus, including additional upstream ones not shown
1, no template; 2, line Y374/001; 3, line Y374/001ΔDRR; 4, line Y374/028; 5,
77 (Schedl et al., 1996).
567D.A. Kleinjan et al. / Developmental Biology 299 (2006) 563–581was observed in the optic vesicle and the overlying surface
ectoderm (Fig. 3E). In E10.5 brains τGFP expression could be
observed in telencephalon, diencephalon and rhombencepha-lon, as well as the spinal cord (Figs. 4A, B). In the eye
expression was clearly visible in both lens and retina (Figs. 4G,
H). The typical Pax6 expression pattern in the hindbrain was
568 D.A. Kleinjan et al. / Developmental Biology 299 (2006) 563–581reproduced in the transgenic embryos, with expression absent in
rhombomere 1 (Rh1) at this stage, strong expression in Rh2 and
Rh3, weaker expression in Rh4-6, and stronger expression from
Rh7 to caudal along the spinal cord (Figs. 4M, N). Later in
development at E17.5 expression can be seen in the cerebral
cortex, olfactory bulbs, ventral thalamus, pretectum, and the
pineal gland (Figs. 5A, B), as well as in the pontine nuclei and
pontine migratory streams and in the cerebellum (Figs. 5G, H).
Expression in cerebellum was weak in comparison with the high
endogenous expression level in this tissue (Engelkamp et al.,
1999). Similarly, expression was detected in the olfactoryepithelium (not shown), but at lower level than expected. The
use of the τGFP reporter allowed cellular processes to be
visualized. This effect is most clearly visible in the labeling of
the axonal projections of retinal ganglion cells, which can be
seen in the optic nerve and followed through the optic chiasm
into the optic tract (Figs. 5G, H).
We proceeded to study the expression patterns generated in
embryos carrying truncated versions of the reporter YACs. Line
Y001 is a single-copy line lacking between 10 and 20 kb of the
distal downstream tip of the full-length YAC sequence (Fig. 2D,
see also Fig. 7). The pattern of GFP expression in this line
Fig. 3. GFP expression in E9.5 embryos. (A) The GFP signal in Y223 reproduces the known Pax6 expression pattern with expression in the eye, telencephalon,
diencephalon, rhombencephalon and spinal cord. (B) GFP expression is similar to panel (A) with exception of prosomere P2 of the diencephalon where expression is
lacking in line Y001. (C) Deletion of the DRR results in loss of expression from prosomere P1 of the diencephalon as well as from the optic vesicle. Expression in
prosomere P3 appears to be upregulated. (D) Truncated line Y028 shows expression in hindbrain and spinal cord, but completely lacks expression in forebrain and
optic vesicle. (E) Frontal view of line Y223 shows expression in optic vesicle and surface ectoderm. (F) Line Y001 has expression in both optic vesicle and surface
ectoderm, but (G) line Y001ΔDRR no longer expresses GFP in the optic vesicle while maintaining surface ectoderm expression. (H) A very weak surface ectoderm
signal can be observed in line Y028. NT, neural tube; E, eye; D, diencephalon; OV, optic vesicle; SE, surface ectoderm.
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DTy54, with some notable differences. The first conspicuous
difference from the full-length lines Y223 and DTy54 was the
absence of expression in the P2 region of the diencephalon at
E9.5 and E10.5 (Figs. 3B, F; 4C). Expression in the eye (Fig. 4I)
and rhombencephalon (Fig. 4O) was normal. At E17.5
expression was similar to line Y223 and DTy54 (Figs. 5C, I)
with exception of the notable absence of expression in the
pineal gland (Fig. 5C).
Expression in line DTy22, truncated between 50 and 75 kb
downstream from the PAX6 P1 promoter (see Figs. 2D and 7),
was more restricted compared to line Y223. At E10.5
expression was similar to Y223 in telencephalon, rhomben-Fig. 2. (A) Schematic map of YAC Y374 with the positions of the LoxP and FRT sites
tGFP-IRES-Neomycin cassette, indicated by a green box, was inserted. Red balls sho
the positions of the cosmids used as probes in the FISH analysis of the transgenic line
11M20 with FITC. (B) Magnification of the DRR containing region of YAC Y374 f
mediated deletion are indicated. The gel photo shows the loss of the DRR region in th
expressing female. The newly established line was named Y001ΔDRR. After Cre-m
Y001, have come into close proximity and give a band of the expected size. PCR prod
are no longer found in line Y001ΔDRR. M, marker; lane 1, no template; lane2, line Y
spleen cells from the individual transgenic lines. Cosmids used as probes were labele
for cP60, located upstream of PAX6, and for cFAT5, encompassing the PAX6 transcrip
or absence of probes cC1170 and c11M20. Lines Y223, DTy54 and Y001 all contain
both c11M20 and c1170. Deletion of the DRR region from Y001 by Cre-mediated re
from the YAC transgene, and as a result Y001ΔDRR is negative for c11M20 signal. F
YAC arranged in a head to head, tail to tail order (arrowhead). The other lines are all s
Lines DTy54 and DTy22 are made with YAC Y1123. DTy54 is a single-copy full-leng
from the P1 promoter, just before a conserved sequence named E100. Y223, Y001 a
from Y001 by Cre-mediated deletion of the DRR. Y223 carries 6 copies of the transg
downstream tip of the YAC including a highly conserved sequence element, RB. Y
promoter, between ELP4 exon 10 and another highly conserved region termed E60+cephalon and neural tube (Figs. 4D, P), but different in the
diencephalon with expression missing from both prosomeres P1
and P2, while expression in P3 appeared to be upregulated (Fig.
4D). In the eye expression was not observed in the retina, but
clearly present in the lens (Fig. 4J). As in line Y001 expression
was absent from the pineal gland at E17.5 (Fig. 5D). Expression
in the thalamic region of the brain, still present in Y001, was not
seen in line DTy22 (Fig. 5D). Furthermore, in the pontine region
of the brain the distinct Pax6 expression pattern in the pontine
nuclei and migratory streams is not observed, but signal is still
seen in the underlying part of the pons (Fig. 5J).
Finally we examined GFP expression in line Y028. Y028
truncates between 30 and 42 kb from the P1 promoter,indicated. The PAX6 transcription unit is indicated by a purple box into which a
w the positions of some relevant enhancers for PAX6. Shown below the YAC are
s. Cosmids P60 and C1170 were labelled with TexasRed and cosmids FAT5 and
lanked by LoxP sites. The positions of the PCR primers diagnostic for the Cre-
e offspring of cross between a transgenic male of line Y001 and a germline Cre-
ediated deletion primers Pr363 and Pr127, which are 35 kb apart in parent line
ucts spanning the distal LoxP/FRTsite or recognizing a fragment within the DRR
001; lane3, line Y001ΔDRR; lane4, non-transgenic mouse. (C) FISH analysis on
d in red (cP60 and cC1170) or green (cFAT5 and c11M20). All lines are positive
tion unit. The variable extent of integration of the YAC is shown by the presence
both these probes, but DTy22 is negative for c11M20 and Y028 is negative for
combination has caused the deletion of the nearly full extent of cosmid c11M20
ISH signal from interphase nuclei of line Y223 shows it to carry 6 copies of the
ingle copy. (D) Summary of the YAC transgenic lines characterized in this study.
th YAC insert, DTy22 is a single-copy line truncated around 100 kb downstream
nd Y028 are made by microinjection of YAC Y374, and Y001ΔDRR is derived
ene including full-length ones. Y001 lacks between 10 and 20 kb from the distal
028 is severely truncated, terminating at 30 to 40 kb downstream from the P1
.
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entire downstream region (Figs. 2D and 7). Expression in this
line was severely restricted. At E9.5 expression was present in
hindbrain and neural tube, but lacking entirely in the brain (Fig.
3D). No expression was seen in the eye with exception of a
weak signal in the surface ectoderm (Fig. 3H). Similarly, at
E10.5 expression could only be observed in the spinal cord and
rhombencephalon (Fig. 4E). In the eye a very weak signal wasFig. 4. Expression in E10.5 embryos. (A, G, M) Line Y223 as well as (B, H, N) line D
nervous system in telencephalon, diencephalon, rhombencephalon and spinal cord. (
expression conforms to the known rhombencephalic pattern for Pax6. No expressio
columns in Rh2 and Rh3. Expression in Rh4-6 is weaker in two columns and lacking
along the length of the spinal cord. (C, I, O) Expression in line Y001. (C) In the brai
seen in both lens and retina. (O) Normal Pax6 expression in hindbrain. (D, J, P) In line
expression is found the retina, but (P) expression in hindbrain is normal. (E, K, Q) Lin
seen in the eye apart from a very weak signal in the lens. (Q) Expression is found in sp
(F, L, R) Expression in line Y001ΔDRR needs to be compared to line Y001 (C, I,
lacking in prosomeres P1 and P2. (L) Expression is present in the lens, but absent fr
cord. SC, spinal cord; HB, hindbrain; E, eye; T, telencephalon; P1-3, prosomeres P
hindbrain.seen in the lens, while expression in the retina was absent (Fig.
4K). Expression in rhombencephalon was normal, apart from an
apparent upregulation of GFP signal in Rh3 (Fig. 4Q). The only
expression seen in Y028 brains at E17.5 was in the interior part
of the pons (Figs. 5E, K). All other, more rostral regions of the
brain were negative for GFP. No signal was observed in the
pontine nuclei or pontine migratory streams. However,
expression of τGFP in the interior region of the pons appearedTy54 show a complete Pax6 expression pattern. (A, B) Expression is seen in the
G, H) In the eye expression is found in lens and retina (M, N) in the hindbrain
n is observed in Rh1 at this stage. Strong expression is found in three lateral
from the lateral most column. From Rh7 to caudal expression is strong and runs
n Y001 lacks expression in prosomere P2 of the diencephalon. (I) GFP signal is
DTy22 expression is absent in prosomeres P1 and P2 of the diencephalon. (J) No
e Y028 lacks expression in telencephalon and diencephalon. (K) No expression is
inal cord and rhombencephalon where the expression in Rh3 appears upregulated
O). (F) GFP signal is seen in the brain in telencephalon and prosomere P3, but
om the retina. (R) A normal expression pattern is found in hindbrain and spinal
1-3 of the diencephalon; L, lens; R, retina; Rh1-8, rhombomeres Rh1-8 of the
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DTy22, suggesting a possible upregulation in this area in Y028.
As mentioned, expression in lines Y223 and DTy54 carrying
the full-length YACs reproduced a nearly complete Pax6
expression pattern. However, some minor exceptions were
noted. Firstly, the levels of expression in both olfactory
epithelium (data not shown) and cerebellum at E17.5 were
lower than expected. In particular the cerebellum expresses
endogenous Pax6 at high levels in comparison with other tissues
(Engelkamp et al., 1999). Although expression was clearly
detectable in the multicopy line Y223, and at lower level also in
lines DTy54 and Y001, this level of expression was very low in
comparison with expression in other regions of the brain, e.g.,
the cortex or olfactory bulbs (Figs. 8A, B). This strongly
suggests that additional cis-regulatory elements for expression
in olfactory epithelium and the cerebellum exist that are located
outside the region encompassed by the YAC. Alternatively
tissue-specific post-transcriptional or post-translational differ-
ences between τGFP and Pax6 could exist. A secondFig. 5. Expression patterns in E17.5 dissected brains, viewed from dorsal (A–F) and
(OB), the cortical lobes (C), the pineal gland (P) and underlying thalamus (Th). (B) Ex
in olfactory bulbs, cortex and thalamus, but absent from the pineal gland. (D) Line DT
and pineal gland. (E) The severely truncated line Y028 lacks all expression in the fo
expression in thalamus and pineal gland, but expression in the olfactory bulbs and co
expression pattern with GFP seen in the olfactory bulbs and cortex, in the axons of
Expression is also observed in the pontine region of the brain (P) with strong expressi
(H, I) Expression in DTy54 and Y001 is as described for Y223. (J) In line DTy22 exp
nerve, chiasm and tract. Expression in the deeper regions of the pons (P) remains, but
Y028 lacks all brain expression with exception of the pontine region where expres
comparison with line Y001 line Y001ΔDRR has lost expression in optic nerve, chiasm
Th, thalamus; P, pineal gland; OB, olfactory bulbs; P, pons; PMS, pontine migratorydiscrepancy between the τGFP pattern observed in our
transgenic lines and the endogenous Pax6 expression pattern
is that no expression could be detected in the pancreas of any of
the lines at E11.5, E17.5 or P4. However, strong GFP expression
was seen in the pancreas of older transgenic mice (>3months)
(not shown). This result was surprising as a recent report
described the presence of pancreatic expression in transgenic
mice carrying a Pax6 GFP reporter BAC containing a smaller
portion of the Pax6 locus than our YAC transgenic lines (Kim
and Lauderdale, 2006). Although unlikely, this could be due to a
species difference as the BAC contains part of the murine Pax6
locus whereas our YACs contain the human PAX6 locus.
However, the original PAX6-expressing YACwas able to rescue
the Pax6 homozygous phenotype, suggesting that in the
transgenic line made with this YAC expression in the pancreas
was normal (Schedl et al., 1996; Heller et al., 2004). Thus far
two enhancers have been described for Pax6 expression in the
pancreas (Kammandel et al., 1999; Xu et al., 1999), located
4.2 kb and 2 kb upstream from the human P0 promoterfrom ventral (G–L). (A) GFP signal in line Y223 is seen in the olfactory bulbs
pression in line DTy54 is identical to Y223. (C) In line Y001 expression is found
y22 has expression in cortex and olfactory bulbs, but no expression in thalamus
rebrain. (F) Deletion of the DRR region in Y001ΔDRR has resulted in loss of
rtical lobes is maintained. (G) A ventral view of a Y223 brain shows a complex
the optic nerve (ON), through the optic chiasm (OC) and into optic tract (OT).
on in the overlying pontine migratory stream (PMS) and the pontine nuclei (PN).
ression is seen in olfactory bulbs and cortex, but no longer observed in the optic
is no longer seen in the pontine migratory stream or in the pontine nuclei. (J) Line
sion appears upregulated in comparison with the other transgenic lines. (L) In
and tract, as well as the pontine migratory stream and pontine nuclei. C, cortex;
stream; PN, pontine nuclei; ON, optic nerve; OC, optic chiasm; OT, optic tract.
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enhancers were not mutated or deleted during the process of
modifying the YACs. The pancreas enhancers were PCR
amplified and sequenced with human-specific primers from
genomic DNA of YAC lines Y223 and PAX77. Both sets of
sequences were identical to each other and to the Genbank
sequences for the regions (not shown).
Analysis of RBZ reporter expression in transgenic lines
As described line Y001 lacks between 10 and 20 kb of
sequence from the very 3′ end of the insert compared to lines
DTy54 and Y223 who both contain the full-length YAC. Y001
also lacks a subset of the expression pattern observed in lines
DTy54 and Y223, notably expression is absent from the P2
region of the diencephalon at E9.5 and E10.5 and from the
pineal gland at E17.5. To determine whether the region missing
in line Y001 would contain tissue-specific enhancer(s) for
prosomere P2 and pineal gland we examined a PIP plot of the
region for conserved sequence elements (Fig. 6). One region of
high conservation between the human, mouse and chicken
sequences stood out in the 20 kb region at the distal end of the
YAC insert. This element, which we have termed RB, has 94%
conservation over 1100 bp between mouse and human, and is
conserved to many species including chicken (87% over
835 bp), Xenopus, fugu and zebrafish. We have tested the
enhancer capability of this element in transgenic mice using a
minimal promoter-LacZ reporter cassette. Out of 20 indepen-
dent transgenic offspring obtained at least 11 showed
expression of the LacZ reporter gene. Six expressing lines
were studied in detail at different embryonic stages. In E8.5
embryos transgene expression was seen along the midline in the
forebrain region (Fig. 7A). By E9.0 expression was in the
diencephalic region of the brain, becoming localized to the P2
region by E9.5 (Fig. 7B). A narrow line of expressing cells was
also observed on either side of the midline in the P1 region
spreading into the midbrain domain. Expression was also
observed on either side in the dorso-medial regions of the
telencephalic bulges (Fig. 7C). At E10.5 and E11.5 expression
remained strong in the P2 region of the diencephalon and
increased in intensity in the telencephalic region in most of the
transgenic lines (Figs. 7D–G). At E 17.5-specific X-gal staining
driven by the RB element can be observed in the pineal gland
and the cortical hemispheres (Figs. 7H, I). In a number of
independent lines additional expression is seen in the olfactory
bulbs (Fig. 7H). Thus the lack of expression in prosomere P2Fig. 6. Annotated percentage identity plot (Schwartz et al., 2000) of the Pax6 locus ext
within the YACs. The murine sequence, being more compact than the human locu
chicken PAX6/Pax6 loci. The length of the Pax6 transcription unit is depicted in yellow
in which the truncated downstream end of the individual YAC transgenes lies is marke
indicated by vertical lines, with red and blue arrowheads marking LoxP and FRT s
highlighted with blue boxes. P/EE, pancreas/ectodermal enhancer (Williams et al., 19
retinal enhancer (Plaza et al., 1995a; Kammandel et al., 1999), 7CE2, diencephalon en
preparation); E100, C1170box123 enhancer (Griffin et al., 2002), EI/SIMO, lens, di
(Kleinjan et al., 2001). Inspection of the PIP plot for the region between the 3′ ends of
which we have termed RB. The enhancer regions analyzed in Figs. 7 and 8, RB anand pineal gland in YAC transgenic line Y001 can be attributed
to the absence of cis-element RB (Table 1).
The RB enhancer element is not Pax6-dependent
Previously we have described a cis-regulatory element in
intron 7 of Pax6 capable of driving reporter gene expression in
prosomeres P1 and P2 of the diencephalon. Expression driven
by that element in the P2 region was shown to be under
autoregulatory control, even though the endogenous gene
remains transcribed in P2 in the absence of Pax6. This
suggested the existence of an additional enhancer that would
be active in the P2 region independent of Pax6 itself. Since the
RB element drives expression in prosomere P2 we wanted to
assess whether or not RB activity in P2 would be dependent on
Pax6 functional activity. We therefore crossed the RB transgene
onto the mouse small eye (Pax6SeyEd) background. A further
cross with a small eye female resulted in a litter containing the
RB-Z transgene on wildtype, heterozygous and homozygous
Pax6Sey backgrounds. Examination of E11.5 homozygous
small eye mutant embryos carrying the transgene revealed the
RB driven reporter expression pattern is identical to the RB
pattern in wildtype embryos (Fig. 7J), indicating the RB
element does not require functional Pax6 for its enhancer
activity.
CRE-mediated deletion of the DRR from YAC line Y001
A characteristic feature of transgenic experiments is the
unpredictability of the transgene insertion site into the genome.
It is well known that the local chromatin environment at the site
of insertion can have a strong influence on the expression status
of the transgene, thus obstructing a direct comparison between
various independent transgenic lines inserted at random into the
genome. Even though this is generally considered less
problematic with large constructs such as YACs, we wanted
to determine unambiguously the role of the downstream
regulatory region (DRR) in regulating Pax6 expression. To
enable a direct comparison between a DRR containing and a
DRR lacking transgenic line we have flanked this region in one
of our reporter YACs with LoxP sites (YAC374; see Fig. 1).
Cre-mediated deletion of the DRR after establishment of a
transgenic line would generate two transgenic lines that are
genetically identical except for the presence or absence of the
DRR. One of our transgenic lines, line Y001, proved most
suitable for this experiment, and was crossed to a germ-lineending from 20 kb upstream of the P0 promoter to the downstream end contained
s, was used as baseline. Pairwise comparisons were made with the human and
and the Elp4 transcription unit in orange. Exons are shown in pink. The interval
d above the plot. The positions of the two LoxP sites inserted into YAC Y374 are
ites respectively. Conserved enhancer sequences of relevance to this study are
98; Kammandel et al., 1999), P, pancreas enhancer (Xu et al., 1999), α, intron 4
hancer (Kleinjan et al., 2004); E60+, ultraconserved enhancer (Kleinjan et al., in
encephalon, hindbrain enhancer (Kleinjan et al., 2001), HS2/3, retinal enhancer
Y001 and Y223/DTy54 revealed the presence of one highly conserved fragment,
d EI, are marked with red boxes.
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Fig. 7. LacZ reporter expression in transgenic embryos for construct RB-Z. (A) In E8.5 embryos transgene expression is seen in the future forebrain region. (B, C) By
E9.5 expression is seen in the diencephalic region of the brain, with strongest staining in the prosomere P2 region, extending in narrow line of expressing cells on either
side of the midline through the P1 region and into the midbrain domain. In most lines some staining is also observed in the dorso-medial regions of the telencephalic
bulges. The expression in the genital ridge is due to site of integration of the transgene. (D, E, F) At E10.5 and E11.5 expression remained strong in the P2 region of the
diencephalon and increased in intensity in the telencephalic region in most (E, G), but not all (F), of the transgenic lines. (H, I, K) At E 17.5 the expression pattern
driven by the RB element has become complex. All embryos show strong expression in the pineal gland. Most of the independent embryos also express in the cortical
hemispheres, while in a smaller number of lines additional expression is seen in the olfactory bulbs. E, eye; F, forebrain; T, telencephalon; P2, prosomere P2 of the
diencephalon; D, diencephalon; C, cortex; OB, olfactory bulbs; P, pineal gland.
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construct in which Cre is under control of a chicken β-actin
promoter (Araki et al., 1995)). The resulting transgenic line was
called Y001ΔDRR, and tested genotypically to ensure that
proper deletion of the region between LoxP sites had taken
place. PCR analysis with primers on either side of both LoxPTable 1
Summary of reporter gene expression in full-length and truncated YAC transgenic l
Line E10.5
SC HB T P1 P2 P3 Ret Lens
Y223 + + + + + + + +
DTY54 + + + + + + + +
Y001 + + + + − + + +
Y001ΔDRR + + + − − + − +
DTY22 + + + − − + − +
Y028 + + − − − − − +/−
Abbreviations: SC, spinal cord; HB, hindbrain; T, telencephalon; P1, prosomere P
olfactory bulb; C, Cortex, Cb, cerebellum; ON, optic nerve; PMS, pontine migratorsites as well as with primers out with the deletion were used to
show the removal of the 35 kb DRR region in line Y001ΔDRR
(Fig. 2B). PCR with primer pair Pr126/127, located around the
distal LoxP site gave the expected band in parent line Y001, but
this band was no longer obtained in line Y001ΔDRR. PCR
with Pr363, located just upstream of the proximal LoxP site,ines
E17.5
OB C Cb ON Pons PMS PN Th P
+ + + + + + + + +
+ + + + + + + + +
+ + + + + + + + −
+ + − − + − − − −
+ + − − + − − − −
− − − − + − − − −
1 of the diencephalon; P2, prosomere P2; P3, prosomere P3; Ret, retina; OB,
y stream; PN, pontine nuclei; Th, Thalamus; P, pineal gland.
Fig. 8. The DRR harbors an enhancer for expression in cerebellum. (A) Side
view of an E17.5 brain of multicopy line Y223, showing expression in the
cerebellum (white arrowheads). (B) In the single-copy line Y001 is weak but
clearly present. (C) After deletion of the DRR in line Y001ΔDRR expression in
cerebellum is no longer observed. (D) No cerebellar expression can be found in
the truncated line Y028. (E) LacZ staining of a transgenic E17.5 brain for
construct EIZ, containing two conserved elements located within the DRR,
shows this enhancer is capable of driving expression in the cerebellum at this
stage. (F) Additional staining is found in the pineal gland, identifying a second
enhancer for pineal gland expression in the PAX6 locus. P, pineal gland; C,
cortex; OB, olfactory bulbs.
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negative in Y001 as these primers are 35 kb apart in this line,
but positive in Y001ΔDRR as after the deletion these primers
have been brought into close proximity (Fig. 2B). Finally,
primer pair Pr128/Pr260, located within the DRR, produced a
band from Y001 template, but not from Y001ΔDRR. The
successful deletion of the DRR was further confirmed by FISH
analysis on spleen cells derived from Y001 and Y001ΔDRR,
using cosmid 11M20 as probe for the DRR region. The DRR
constitutes nearly the full genomic insert of this cosmid and its
deletion from line Y001ΔDRR results in an absence of FISH
signal, whereas a clear signal is present in its parent line Y001
(Fig. 2C).
Comparison of Y001 and Y001ΔDRR after deletion of the DRR
Having confirmed the deletion of the DRR region we
proceeded to examine the effect on expression of the reporter
gene by comparison of Y001 and Y001ΔDRR embryos at E9.5,
E10.5 and E17.5. At E9.5 and E10.5 line Y001 showed
expression in the prosomere P1 region of the diencephalon,
whereas expression was no longer seen at this site in
Y001ΔDRR embryos (Figs. 3C and 4F). In the developing
eye at E9.5 Y001 is expressed in the optic vesicle and surface
ectoderm. While expression in surface ectoderm is maintained,
expression in the optic vesicle is no longer observed after
deletion of the DRR (Figs. 3C, G). Similarly at E10.5, when
Y001 has strong expression in both lens and retina,
Y001ΔDRR maintains lens expression but expression in the
retina is completely lost (Fig. 4L). At E17.5 deletion of the DRR
caused loss of expression in the thalamic region of the brain
(compare Figs. 5C and F). In the eye, expression in the ganglion
cell layer of the retina is lost, and as a result τGFP is no longer
seen in the optic nerve, chiasm and tract (Fig. 5L). In the pontine
region of the brain the distinctive expression in the pontine
migratory stream and pontine nuclei seen in Y001 is no longer
present (compare Figs. 5I and L). Finally, the low level
expression in the cerebellum of Y001 (Fig. 8B) is absent upon
deletion of the DRR (Fig. 8C), suggesting a role for the DRR in
driving cerebellar PAX6 expression.
We have also examined τGFP expression in sections through
E17.5 eyes. In the eyes from lines Y223 and Y001 the observed
expression matches the known PAX6 expression pattern. τGFP
can be seen in the corneal epithelium, lens epithelium, iris and
ciliary body. Expression is also seen in the neural retina, with
strong expression in the ganglion cell layer (GCL), which at this
stage contains retinal ganglion cells (RGCs) and amacrine cells,
and much weaker staining in a subset of cells in the neuroblast
layer (NBL) (Figs. 9A, B, E, F). The presence of τGFP along
the RGC axons generates a strong GFP signal in optic nerve. In
both line Y001ΔDRR and line Y028 the τGFP signal in the eye
is severely reduced (Figs. 9C, D, G, H), as evidenced by a 20
times longer exposure time required for the photographs of the
Y001ΔDRR and Y028 sections compared to those of Y223 and
Y001 (Fig. 9). In line Y001ΔDRR GFP signal remains visible
in the corneal epithelium and very weakly in some cells in the
GCL and NBL, but has disappeared from the retinal ganglioncells, lens epithelium, iris and ciliary body (Figs. 9C, G). In the
eyes of Y028 embryos expression mirrors that of line
Y001ΔDRR, but surprisingly a relatively stronger τGFP signal
is seen in a layer of cells in the GCL and NBL, despite Y028
being a more severely truncated transgene (Figs. 9D, H). As no
τGFP is seen in the axons of the RGCs going into the optic
nerve, the positive cells within the GCL are likely to be
amacrine cells. GFP is also seen in a layer of differentiating
neuroblasts within the NBL whose identity is under further
investigation (Fig. 9D, white arrowhead).
In conclusion, removal of the downstream regulatory region
from the YAC transgene as the only genetic difference between
lines Y001 and Y001ΔDRR has resulted in multiple distinct
differences in their expression patterns, demonstrating unequi-
vocally the essential role of the DRR in driving expression in
these regions.
The EI enhancer region controls Pax6 expression in cerebellum
The observation that expression in the cerebellum was lost in
line Y001ΔDRR led us to re-examine a transgenic line carrying
the EI-Z construct. The EI-Z construct is a minimal promoter-
LacZ reporter cassette under control of a 2.5-kb fragment
encompassing the SIMO aniridia patient breakpoint region
including two fragments of highly conserved sequence
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has been described for early developmental stages (Kleinjan et
al., 2001), but was not examined for later stages. At
midgestation X-gal staining was seen in lens, diencephalon
and in a specific pattern in the rhombencephalon, suggesting the
possibility of expression in the cerebellum later in development.
Indeed when expression was checked in E17.5 dissected brains
staining was observed in the cerebellum (Fig. 8E). This suggests
that the EI region, located 150 kb from the P1 promoter,
controls at least in part expression of PAX6 in cerebellum.
Reporter expression generated by the EI transgene was also
found in the pineal gland (Fig. 8F), indicating that expression in
that organ is under control of at least two enhancers, one located
in the EI fragment and another in the RB fragment.
Overexpression of a short PAX6 isoform causes
microphthalmia
The surprisingly low expression level in cerebellum,
olfactory epithelium and the apparent absence of expression
in the embryonic pancreas led us to attempt to further increase
GFP signal strength in our strongest expressing line, theFig. 9. τGFP expression in E17.5 eyes on 20 μ cryosections. (A–D) τGFP signal
epithelium, lens epithelium, iris, and ciliary body (CB). In the retina strong expression
amacrine cells, with weak expression in a subset of cells in the neuroblast layer (NBL
in the optic nerve (ON). (B, E) Expression in line Y001 is the same as for line Y223,
GCL and a subset of cells in the NBL of the neural retina. (C, G) Expression in lin
remaining in the corneal epithelium and very weakly in the GCL and NBL, but a
expression as Y001ΔDRR, but relatively stronger expression in a cell layer within
neuroblasts in the NBL (white arrowhead). Note that panels C, D, G and H required 2
epithelium, L, lens, GCL, ganglion cell layer, NBL, neuroblast layer, ON, optic nermulticopy line Y223, by breeding this line to homozygosity.
Unexpectedly this resulted in a strong eye phenotype in the
homozygous offspring, whereas no obvious phenotype had
been seen in the hemizygotes (Fig. 10A). The homozygous eye
phenotype includes small eyes with abnormal iris, ectopic
pigmentation, and retina, lens and ciliary body malformations
and a high frequency of ectopic pupils (Fig. 10A). Closer
inspection of hemizygous eyes revealed the occasional
occurrence of ectopic pupils, but no reduction in eye size. As
the τGFP-neomycin-polyA reporter cassette has been inserted
into the PAX6 translational startcodon in exon 4 we had
assumed to have knocked out PAX6 expression from the YAC
transgene. However, in addition to the major PAX6 promoters
P0 and P1 (Plaza et al., 1995a,b; Anderson et al., 2002), located
upstream of exon 4, two less well-characterized promoters have
been reported that are located downstream of the reporter
insertion site in exon 4 (Kammandel et al., 1999; Kleinjan et al.,
2001). Transcripts originating from those promoters would
bypass the reporter cassette and give rise to a shorter PAX6
isoform lacking the paired domain (Fig. 10B). The existence
of such an isoform has been observed in quail, as well as in a
C. elegans Pax6 homologue (Carriere et al., 1993; Chisholmonly (E–H) τGFP plus DAPI. (A, E) Line Y223 shows expression in corneal
is seen in the ganglion cell layer (GCL) including the retinal ganglion (RGC) and
). The presence of GFP in the axons of the RGCs gives rise to the strong staining
with GFP signal in corneal epithelium, lens epithelium, iris/ciliary body and the
e Y001ΔDRR is severely reduced in comparison with Y001, with GFP signal
bsent from lens, ciliary body and the RGCs. (D, H) Line Y028 shows similar
the GCL, most likely to be amacrine cells, and in a subset of differentiating
0 times longer exposure time than panels A, B, E, F. CB, ciliary body, C, corneal
ve.
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our observation was confirmed by a report describing a similar
result in a multicopy BAC transgenic line where GFP was also
inserted at the ATG in exon 4 (Kim and Lauderdale, 2006). In
that study it was determined using a 5′-RACE method that
during eye development an alternative Pax6 transcript
originating from the alpha promoter in intron 4 is indeed
made. No transcripts were found that initiate from the putative
promoter in intron 7. We decided to determine whether this
same transcript is also made in our reporter transgenic lines,
using RT-PCR on RNA made from the heads of E10.5
transgenic embryos and non-transgenic littermates. As theFig. 10. Overexpression of a short PAX6 isoform causes microphthalmia. (A) Mice h
the transgene) have moderate to severe microphthalmia, sometimes in combination w
littermates. (B) Schematic map of the PAX6 transcription unit. PAX6 exons are show
into the canonical PAX6 translational start site in exon 4. Positions of known PAX6
used in the RT-PCR reactions in panel C are indicated. Pr3F1675 is a human-specific
reverse primer located in exon 9. (C) Gels showing the results of RT-PCR reactions
transgenic embryo and a non-transgenic littermate. RNA made from the PAX6 posit
where reverse transcriptase was added to the reaction, while − indicates where it was le
ubiquitously expressed ELP4/Elp4 cDNA are used as control for the RT reaction. N
transcription from promoters P0 and P1 is effectively stopped at the tGFP/Neo
demonstrating the presence of a shorter PAX6 transcript initiated from the Pα promote
the CD5a cell line.YAC contains the human PAX6 locus, human-specific primers
could be used to report only on reporter YAC derived
transcripts. RT-PCR with primers 3F1675, specific for human
exon 3, and reverse primer Pr050, located in exon 9, showed
an absence of P0 or P1 derived transcripts in the E10.5
transgenic mouse embryo, while it is clearly present in the
human control cell line CD5a (Fig. 10C) (Kleinjan et al.,
2001). This demonstrates that the reporter cassette containing
exon 4 does not get spliced out. RT-PCR between primer αF,
specific for human exon α, and Pr050 detected the presence of
a transcript of the expected size in the transgenic embryo, but
not in a non-transgenic littermate, thus confirming theomozygous for the 6-copy YAC transgenic line Y223 (thus carrying 12 copies of
ith cataracts. No obvious phenotype was seen in heterozygous or non-transgenic
n as blue boxes. The tGFP-IRES-Neomycin-polyA reporter cassette was inserted
promoters are indicated by arrows. Below the map the positions of PCR primers
primer in exon 3, primer aF is a human-specific primer in exon alpha, Pr050 is a
with three primer sets on RNA made from the head region of an E10.5 Y001
ive human lens cell line CD5a is used as control. Lanes marked with + indicate
ft out. Primer pair Pr087/Pr088, recognizing both human and mouse forms of the
o product is found with primers Pr3F1675 and Pr050 in line Y001 indicating
mycin-polyA cassette. Primer pair PraF/Pr050 gave a band in Y001 cDNA
r. Both long (P0 or P1 derived) and short (Pα derived) isoforms are transcribed in
578 D.A. Kleinjan et al. / Developmental Biology 299 (2006) 563–581existence of Pα initiated transcripts in the heads of E10.5
embryos (Fig. 10C). Interestingly this transcript was also
found in the CD5a control cell line. In combination with the
report by Kim these results strongly suggest that the observed
eye phenotype in the multicopy reporter transgenics is due to
the overexpression of this shorter paired-less PAX6 isoform.
Discussion
Developmental regulator genes occupy crucial positions in
the genetic networks that control the development and
maintenance of our organ systems, often fulfilling multiple
functions at different places and timepoints in the embryo. This
role requires very complex but strictly regulated control of gene
expression. Thus many such genes reside in extended and
intricate regulatory landscapes. Previous work on the regulation
of PAX6 has shown that while it has a relatively compact
transcription unit it requires a large intact genomic domain for
proper expression and function (Kleinjan et al., 2001).
Multispecies sequence comparisons of the Pax6 locus have
revealed a large number of evolutionarily conserved regions
(ECRs), not all of which have been characterized to date (see
Fig. 7). Furthermore, the expression of reporter transgenics
carrying small, isolated putative regulatory elements is subject
to external effects due to site of integration as well as to the
unnatural configuration of multicopy transgene arrays that is
nearly always produced with small transgenes. Most impor-
tantly, such analyses neglect the potential interactions that
occur between regulatory regions in the intact endogenous
locus. To study the genomic requirements for correct Pax6
expression we have modified a yeast artificial chromosome
(YAC) containing 420 kb of the human PAX6 locus by
inserting a τGFP-Neomycin reporter gene in frame into the
main PAX6 translational start site. Previous analysis of
transgenic mice made with the unmodified YAC had shown it
to be capable of rescuing the phenotype of the Pax6 mutant
smalleye (Pax6SeyEd), and it was therefore expected to carry
most or all of the PAX6 regulatory domain (Schedl et al., 1996).
Analysis of the τGFP signal in two full-length transgenic lines
indeed reproduced a complete Pax6 expression pattern, but
with exception of expression in the developing pancreas. The
absence of visible τGFP signal in the pancreas is puzzling since
GFP was observed in transgenic mice carrying a Pax6 GFP
reporter BAC containing a smaller portion of the Pax6 locus
than our YAC transgenic lines (Kim and Lauderdale, 2006).
While the BAC contains the murine locus whereas our YACs
contain the human locus a species difference seems unlikely
since the original PAX6-expressing YAC was able to rescue the
Pax6 homozygous phenotype, suggesting that in the transgenic
line made with this YAC expression in the pancreas was normal
(Schedl et al., 1996; Heller et al., 2004). Thus far two enhancers
have been described for Pax6 expression in the pancreas
(Kammandel et al., 1999; Xu et al., 1999), located 4.2 kb and
2 kb upstream from the human P0 promoter respectively. If a
mutation had been introduced in either of these during the
process of modifying the YACs it could explain the discrepancy
and furthermore potentially lead to identification of an essentialbinding site for Pax6 expression in the pancreas. However,
sequencing of the enhancers in genomic DNA of modified and
unmodified YAC transgenic lines Y223 and PAX77 respec-
tively, revealed both sets of sequences to be identical to each
other and to the Genbank sequences for the regions. One
difference between the reporter used in the BAC mice and our
YAC mice is our use of a tau-GFP fusion gene rather than GFP
itself, leaving the possibility that the tau moiety causes
instability of the reporter specifically in the pancreas. Further
analysis will be required to resolve this issue.
Analysis of GFP expression in transgenic mice carrying full-
length and truncated versions of the modified YAC has led to a
number of conclusions. Firstly, comparison of the expression
patterns generated in mice carrying complete and variously
truncated versions of the YAC transgene has allowed the
assignment of essential regulatory functions to specific intervals
in the PAX6 downstream region. Using multispecies sequence
conservation as a guide within these intervals we have
subsequently homed in on putative cis-regulatory elements
carrying out these functions by small element reporter
transgenics. Using this approach we have identified a novel
enhancer, which we have named RB, which drives expression in
the P2 region of the diencephalon at midgestation and in the
pineal gland at later stages. It also directs expression in the
dorsal part of the telencephalon and in the olfactory bulbs in
most, but not all independent transgenics. This enhancer is the
most distal Pax6 enhancer identified to date located 210 kb
downstream from the PAX6 P1 promoter.
The loss of expression in cerebellum upon deletion of the
35 kb DRR in line Y001ΔDRR revealed the putative presence of
an enhancer for this tissue in the DRR region.We had previously
made LacZ reporter transgenics with a fragment from within the
DRR, construct EI-Z, and shown expression in a specific pattern
in rhombencephalon at midgestation (Kleinjan et al., 2001),
making one of the two highly conserved elements within the
EI-Z construct a very good candidate to be a cerebellum-specific
enhancer. Here we show that at E17.5 construct EI-Z does indeed
drive expression in cerebellum. A third region harbouring
elements of high sequence conservation is located in the region
between the ends of the integrated transgene in lines DTy22 and
Y028. This region contains an ultraconserved element (Bejerano
et al., 2004) that we have termed element E60+. A detailed
analysis of that element will be described elsewhere (Kleinjan et
al., in preparation), but in summary it drives expression in
telencephalon, the P3 region of the diencephalon (future ventral
thalamus), the optic cup, the rostral migratory stream and
olfactory bulbs, and the pontine migratory stream and nuclei, in
accordance with the absence of expression in all these sites in
Y028 embryos. Indeed, the very limited expression domain
observed in transgenic line Y028 demonstrates the essential role
of the whole downstream region for PAX6 expression.
A second conclusion that can be drawn from our study is that
some enhancers appear to be absolutely essential for expression,
while others may merely contribute to the overall level of
expression in specific tissues. In some cases this could be due to
those elements being the only enhancer for a particular
expression site. For instance we show that the EI fragment
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is the only known enhancer for PAX6 expression there; therefore
it is unsurprising that its absence in line Y001ΔDRR (and
DTy22 and Y028) results in absence of cerebellar expression in
this line. However, the weak expression in cerebellum in the
lines containing the enhancer strongly suggests the presence of
another enhancer required for proper Pax6 expression in
cerebellum, which must be located outside the genomic region
contained in the YAC. Our experience gained through analysis
of many cis-regulatory control elements situated around Pax6
has made clear that multiple enhancers exist for nearly every
Pax6 expression site within the embryo. At present it is unclear
how these regulatory regions cooperate to control Pax6
expression. To start to understand the molecular mechanisms
involved will require the analysis of complete, full-length Pax6
loci with specifically directed mutations/deletions therein, either
in the endogenous locus or in a YAC transgenic system as
described here.
The downstream regulatory region is essential for PAX6
expression
The use of CRE-mediated deletion of the Pax6 distal
regulatory region (DRR) has allowed a direct comparison
between a Pax6 locus with and without this region with the
transgene at the same genomic integration site. A comparison of
expression in the eye between lines Y001 and Y001ΔDRR
highlights two opposing observations: Expression in the retina
has been lost in Y001ΔDRR, while expression in the lens
remains. A previous study has shown that the DRR contains a
number of regulatory elements including a lens-specific element
(the SIMO element, contained in the EI-Z construct) and a
retina-specific element (located within a fragment containing
HS2 and HS3 of the DRR) (Kleinjan et al., 2001). A number of
other cis-regulatory elements are known to drive PAX6
expression in the developing lens including an element located
upstream of the Pax6 P0 promoter, the ectodermal enhancer
(EE) (Williams et al., 1998; Kammandel et al., 1999; Dimanlig
et al., 2001). Thus it may be unsurprising that deletion of the
SIMO element in the DRR has only limited effect on expression
in the lens. It is difficult to estimate the decrease in the level of
GFP expression in the lens, but the GFP signal in
line Y001ΔDRR appears lower overall including in the lens.
This result fits in with the analysis of mice with a targeted
deletion of the ectodermal enhancer where Pax6 expression in
the lens is decreased but not absent (Dimanlig et al., 2001).
Similarly, multiple control elements are known to direct Pax6
expression in the retina, including the well-studied retinal
enhancer in intron 4 of the gene (Plaza et al., 1995a;
Kammandel et al., 1999). However, in contrast to the situation
in the lens, deletion of the DRR, including the retina enhancer in
the HS2/3 fragment, has completely abolished expression in the
retina (see Figs. 4I, L). This demonstrates that the presence of
the DRR is absolutely essential for Pax6 expression in the
retina. Similarly, deletion of the DRR has abolished expression
in iris and ciliary body in E17.5 eyes. The absolute requirement
for the presence of the DRR (or at least some of the enhancerswithin it) can explain why the aniridia phenotype in ‘position
effect’ patients is indistinguishable from aniridia in patients
carrying coding region mutations in PAX6 (Crolla and van
Heyningen, 2002; van Heyningen and Williamson, 2002).
Twomore Pax6 expression sites, prosomeres P1 and P2 of the
diencephalon show the same effect. The DRR contains an
enhancer for expression in the prosomere P1 region of the
diencephalon, located on the previously described EI-Z
transgene (Kleinjan et al., 2001). Two further enhancers are
known to drive expression in the same P1 region of the
diencephalon, the CE2 element in intron 7 and the
C1170Box123 element (renamed to E100 element) (Kleinjan
et al., 2004; Griffin et al., 2002). Nonetheless, deletion of the
DRR results in the total loss of expression in P1, demonstrating
its essential role in Pax6 diencephalic expression. Similarly
expression in P2 is directed through the intron 7 CE2 element
and the RB enhancer, but absence of the latter results in loss of
P2 expression. Unfortunately, the essential nature of the distal
regulatory elements precludes any conclusions about the
specific role of the more proximal elements. For instance, the
E100 element (Griffin et al., 2002) lies within the interval
between the ends of DTy22 and ΔDRR. Since no difference in
GFP expression was observed between those two lines, the
obvious, but incorrect conclusion would be that the interval
between DTy22 and ΔDRR has no regulatory function. This
highlights the value of studying individual cis-elements
alongside larger transgenes.
Twoscenarios thatmayaccount for the observations discussed
above are: (1) there is a requirement for a direct interaction
betweenmultiple enhancers (andpromoters) to set up achromatin
conformation that allows efficient Pax6 transcription to occur. In
the absence of a crucial enhancer such conformation is not made
leading to a failure to initiate transcription; (2) there is a
requirement for the activity of the retina enhancer within the
DRR before other retina enhancers can become active. In the
absence of the ‘initiating’ activity subsequent enhancer function
cannot take place. Further study, in particular the deletion of other
retina enhancers in the context of the intact YAC or the
endogenous locus, is required to distinguish between these
mechanisms.Analternativeexperimentmaybe thedeletionof the
DRR using a Cre transgene under control of the intron 4 retina
enhancer (Marquardt et al., 2001). If the DRR is required very
early indevelopment toactivate theother retinaenhancers, then its
deletion by a ‘later enhancer’ driven Cre should give rise to
continued expressionof theGFP reporter in transgenic lineY001.
Overexpression of a short PAX6 isoform causes
microphthalmia
While breeding the multicopy line Y223 to homozygosity
we noticed a distinct eye malformation, characterized by
moderate to severe microphthalmia, in the homozygous
offspring. This was surprising as we had inserted the reporter
cassette with poly-adenylation sequence into the Pax6 transla-
tional start site in exon 4 of the gene, and included a C2MAZ
sequence (Ashfield et al., 1994) to maximize the likelihood of
transcriptional termination. A number of different Pax6
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promoters that generate transcripts encoding a full-length Pax6
protein containing a paired domain, homeodomain and PST-rich
transactivation domain. Additional promoters have been
identified in intron 4 (Pα) and intron 7 (P4) (Kammandel et
al., 1999; Kleinjan et al., 2004), located beyond the reporter
cassette insertion site. Transcripts initiated from these promo-
ters would give rise to a shorter, paired-less isoform of Pax6.
Such a protein has been described in quail (Carriere et al., 1993)
and C. elegans (Chisholm and Horvitz, 1995; Zhang and
Emmons, 1995). A similar observation of microphthalmia has
been described recently in transgenics with multiple copies of a
BAC that contains part of the murine Pax6 locus, and has a GFP
reporter cassette inserted onto the ATG startcodon in exon 4
(Kim and Lauderdale, 2006). The authors show convincing
evidence for the existence of Pα- but not P4-initiated transcripts
in the eye and olfactory bulb. We have used RT-PCR helped by
the fact that our YAC contains the human PAX6 locus, to
confirm that a Pα derived transcript is made in our YAC
transgenic mice, whereas no evidence was found to suggest that
the reporter cassette containing exon 4 was spliced out in these
animals. As the microphthalmia phenotype is observed in 3
independent multicopy lines (2 BAC and 1 YAC) it is unlikely
to be caused by disruption of a gene at the transgene insertion
site, but most likely to be the result of the overexpression of a
paired-less PAX6/Pax6 isoform. Although initially no pheno-
type had been noticed in the 6-copy Y223 animals, we have
subsequently observed a relatively high incidence of ectopic
pupils in the hemizygous mice. In the case of the BAC
transgenics an eye phenotype was observed with 16 or more
copies, but not in animals with 8 or 10 copies, while in our case
6 copies gives a very mild phenotype and 12 copies a severe
phenotype, possibly suggesting a stronger effect in the YAC.
Interestingly the human lens derived cell line CD5a (Kleinjan et
al., 2001) appears to express both P0/P1 initiated transcripts as
well as the shorter Pα initiated transcript (Fig. 10) providing a
useful source for further study into the role of this shorter PAX6
isoform.
Gene control of complex developmental regulators
In conclusion, our study of full-length and truncated YAC
transgenic mice has provided a wealth of information on the
transcriptional regulation of PAX6. As shown here and in
previous studies PAX6 has a large, extended control region
containing many, complex cis-regulatory elements which
interact in ways that are as yet poorly understood. Such
complex transcriptional regulation involving large numbers of
cis-elements is typical of many genes fulfilling complex roles
as developmental regulators (Kleinjan and van Heyningen,
2005). The PAX6 gene is an excellent paradigm for this
category of genes. The use of transgenic vectors with very
large inserts (YACs or BACs) encompassing the (nearly) full
gene locus is essential for the study of gene expression control
for these developmental regulator genes. Combining these
studies with small element transgenics provides a powerful
approach to characterize the often highly complex interactionsbetween multiple cis-elements required to drive the correct
level of expression in a particular spatiotemporally defined
pattern. Our study also highlights the need for a more
complete view of the full regulatory code embedded in the
gene locus, as multiple control elements may carry out
overlapping and yet interdependent functions. Functional
inactivation, through mutation, deletion or relocation, of any
of these cis-elements can be a distinct cause of genetic
disease.
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